Last week, the world took great note of reports that Israeli cancer researchers believe they are just one year away from developing a cure for cancer and that the treatment would be quick with very limited side effects.

So what is different about the way Accelerated Evolution Biotechnologies is approaching the fight against cancer and is all the excitement warranted? What other hurdles need to be cleared before clinical trials can begin? And how could it be done with minimal side effects on patients?

Greg Corombos gets answers from Stanford University oncologist Dr. Joshua Mansour, who also updates other promising efforts to effectively treat the scourge of cancer.